ArticleBMC musculoskeletal disorders2025
Defining region and duration-specific substantial clinical benefit values for the simplified Chinese lower extremity functional scale.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Patient-reported outcomes as markers and predictors of functional recovery in musculoskeletal rehabilitation.Rheumatology international · 2026Review
- The reliability and validity of a visual analog scale for rating the single leg squat test.PeerJ · 2026Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA single substantial clinical benefit (SCB) value for the Simplified Chinese Lower Extremity Functional Scale (SC-LEFS) that can be applied to those with lower extremity musculoskeletal injuries is available. However, unique SCB values defined by specific body region and symptom duration may enhance the precision of the SC-LEFS in clinical assessments.
methodsThis study aim to determine unique SCB values for the SC-LEFS based on symptom duration and body region. Patients aged 18-50 years referred to physical therapy with a non-arthritic musculoskeletal injury to the knee or ankle/foot completed the SC-LEFS at initial assessment and 4-weeks follow-up. Demographic information and duration of symptoms was also obtained. Patients were grouped based on symptom duration (≤ 3 months or > 3 months). To determine the SCB change score, patients were classified into "improved" and "not improved" groups based on self-report after 4-weeks of physical therapy. SCB values were determined to best distinguish between the two groups. Receiver operator characteristic (ROC) curve analysis defined the sensitivity and specificity for these SCB values.
results313 patients with a mean age of 33.7 (SD 9.3) years were included in the knee region analysis and 354 patients with a mean age of 32.9 (SD 9.4) years in the ankle/foot region analysis. For those with knee injuries, SCB values of 9.5 and 5.5 were found for patients with symptom duration ≤ 3 months and symptom duration > 3 months, respectively. For those with ankle/foot injuries, SCB values 12.5 and 8.5 were found for patients with symptom duration ≤ 3 months and symptom duration > 3 months, respectively. The sensitivity and specificity for these SCB values ranged from 0.67 to 0.72 and from 0.66 to 0.68, respectively, with area under the cures (AUC) being between 0.67 and 0.72 (95% confidence intervals: 0.57-0.87).
conclusionThis study determined specific SCB values for the SC-LEFS after four weeks of physical therapy based on region of injury and symptom duration. These unique values may better allow clinicians to distinguish those "improved" from "not improved" in Chinese-speaking patients with non-arthritic musculoskeletal knee, ankle, or foot injuries.
trial registrationThis project was registered with the Chinese Clinical Trial Registry (ChiCTR2100052104) on 2021-10-17.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.